We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGL
2501
DELISTED
Engility Holdings, Inc.
EGL
| $288K | ﹤0.01% |
11,181
-627
| -5% | -$16.3K |
|
2502
Banc of California
BANC
$3.27B
| $287K | ﹤0.01% |
23,406
+373
| +2% | +$4.77K |
|
2503
Ennis
EBF
$554M
| $287K | ﹤0.01% |
16,513
-348
| -2% | -$5.86K |
|
|
ATSG
2504
DELISTED
Air Transport Services Group
ATSG
| $287K | ﹤0.01% |
33,539
-1,664
| -5% | -$15.9K |
|
|
VOLT
2505
DELISTED
Volt Information Sciences, Inc.
VOLT
| $287K | ﹤0.01% |
31,568
+12,098
| +62% | +$114K |
|
|
NILE
2506
DELISTED
Blue Nile, Inc.
NILE
| $287K | ﹤0.01% |
8,557
+612
| +8% | +$19.9K |
|
|
GSIG
2507
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $287K | ﹤0.01% |
22,523
+796
| +4% | +$10.8K |
|
|
TAL
2508
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
| $286K | ﹤0.01% |
20,892
-1,145
| -5% | -$24.1K |
|
|
FBC
2509
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $286K | ﹤0.01% |
13,928
-124
| -0.9% | -$2.43K |
|
2510
Argan
AGX
$7.33B
| $285K | ﹤0.01% |
8,210
-101
| -1% | -$3.88K |
|
2511
Lattice Semiconductor
LSCC
$17B
| $284K | ﹤0.01% |
73,687
-3,515
| -5% | -$16.2K |
|
2512
Douglas Dynamics
PLOW
$1.04B
| $284K | ﹤0.01% |
14,287
-797
| -5% | -$16.9K |
|
2513
TFS Financial
TFSL
$5.18B
| $284K | ﹤0.01% |
16,472
+4,258
| +35% | +$72.1K |
|
|
APIC
2514
DELISTED
Apigee Corporation Common Stock
APIC
| $284K | ﹤0.01% |
26,934
-110,264
| -80% | -$956K |
|
2515
Alamo Group
ALG
$2B
| $283K | ﹤0.01% |
6,043
-99
| -2% | -$5K |
|
2516
Kadant
KAI
$3.72B
| $282K | ﹤0.01% |
7,241
-127
| -2% | -$5.59K |
|
2517
Cerus
CERS
$585M
| $281K | ﹤0.01% |
61,961
-1,140
| -2% | -$5.9K |
|
|
MSFG
2518
DELISTED
MainSource Financial Group Inc
MSFG
| $281K | ﹤0.01% |
13,820
-445
| -3% | -$9.49K |
|
2519
TTEC Holdings
TTEC
$119M
| $279K | ﹤0.01% |
10,422
-727
| -7% | -$19.8K |
|
|
AMRI
2520
DELISTED
Albany Molecular Research Inc
AMRI
| $279K | ﹤0.01% |
16,004
-457
| -3% | -$9.3K |
|
|
AMTG
2521
DELISTED
APOLLO RESIDENTIAL MTG INC COM STK
AMTG
| $279K | ﹤0.01% |
22,058
+7
| +0% | +$99 |
|
|
AMCC
2522
DELISTED
Applied Micro Circuits Corporation New
AMCC
| $279K | ﹤0.01% |
52,480
+168
| +0.3% | +$986 |
|
|
HOS
2523
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $278K | ﹤0.01% |
20,562
-798
| -4% | -$14.1K |
|
|
CGI
2524
DELISTED
Celadon Group Inc
CGI
| $278K | ﹤0.01% |
17,361
-118
| -0.7% | -$2.33K |
|
|
CCRN
2525
DELISTED
Cross Country Healthcare
CCRN
| $277K | ﹤0.01% |
20,355
-1,798
| -8% | -$24.4K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.